Viewing Study NCT07050160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-12 @ 11:57 PM
Study NCT ID: NCT07050160
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-11-12
First Post: 2025-06-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant
Sponsor: Lexeo Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arrhythmogenic Cardiomyopathy View
None PKP2-ACM View
None PKP2-ARVC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Arrhythmogenic Cardiomyopathy View
None ACM View
None Cardiomyopathy View
None ARVC View
None Arrhythmogenic Right Ventricular View
None Arrhythmogenic Right Ventricular Dysplasia View
None Genetic cardiomyopathy View
None Gene Therapy View
None PKP2 Gene View
None Plakophilin-2 View
None LX2020 View
None GRIT-PKP2 View
None Ventricular Arrhythmia View
None PVCs View
None Sudden Cardiac Death View
None Cardiac Arrest View